1. Home
  2. SRTA vs VNDA Comparison

SRTA vs VNDA Comparison

Compare SRTA & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SRTA

Strata Critical Medical Inc.

N/A

Current Price

$4.92

Market Cap

442.2M

Sector

N/A

ML Signal

N/A

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$8.19

Market Cap

425.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRTA
VNDA
Founded
2014
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
442.2M
425.5M
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
SRTA
VNDA
Price
$4.92
$8.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$7.63
$13.13
AVG Volume (30 Days)
787.6K
2.6M
Earning Date
02-15-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.50
N/A
Revenue
$268,618,000.00
$212,074,000.00
Revenue This Year
N/A
$12.01
Revenue Next Year
$24.64
$21.57
P/E Ratio
$10.29
N/A
Revenue Growth
70.11
11.12
52 Week Low
$2.35
$3.81
52 Week High
$6.02
$9.60

Technical Indicators

Market Signals
Indicator
SRTA
VNDA
Relative Strength Index (RSI) N/A 68.93
Support Level N/A $6.87
Resistance Level N/A $9.60
Average True Range (ATR) 0.00 0.49
MACD 0.00 0.13
Stochastic Oscillator 0.00 60.87

Price Performance

Historical Comparison
SRTA
VNDA

About SRTA Strata Critical Medical Inc.

Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. Its core services include air and ground logistics, surgical organ recovery, organ placement, and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: